Results 11 to 20 of about 334,470 (291)

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.

open access: yesNew England Journal of Medicine, 2023
BACKGROUND Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of AHREs in patients without atrial fibrillation (
P. Kirchhof   +33 more
semanticscholar   +1 more source

Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum

open access: yesThrombosis Update, 2022
Purpose: Anticoagulation Stewardship is urgently needed to improve anticoagulation management and bend the current, negative trajectory on anticoagulation-related harm.
Allison Burnett   +2 more
doaj   +1 more source

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

open access: yesNew England Journal of Medicine, 2021
Background Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill patients with Covid ...
E. Goligher   +167 more
semanticscholar   +1 more source

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

open access: yesNew England Journal of Medicine, 2021
Background Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients
P. Lawler   +177 more
semanticscholar   +1 more source

Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial

open access: yesCardiovascular Therapeutics, 2023
Background. Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it. Objective.
Litao Zhang   +10 more
doaj   +1 more source

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic prophylaxis.
P. Sadeghipour   +59 more
semanticscholar   +1 more source

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

open access: yesBlood Advances, 2021
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE).
A. Cuker   +44 more
semanticscholar   +1 more source

A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

open access: yesBleeding, Thrombosis and Vascular Biology, 2022
The aim of this essay is to re-consider the peculiar type of thrombogenesis observed in severe cases of COVID-19 infection, focusing on the multiple interconnected networks involved, such as inflammation, blood coagulation, fibrinolysis, and immune ...
Sergio Coccheri
doaj   +1 more source

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded) by laboratory testing, with the activated partial thromboplastin time and dilute Russell's viper venom time ...
Emmanuel J. Favaloro, Leonardo Pasalic
openaire   +3 more sources

Home - About - Disclaimer - Privacy